• Explore /
  • Poster
  • / Feasibility and conduct of INSIGhT, a platform trial of patients with glioblastoma using Bayesian adaptive randomization.

Feasibility and conduct of INSIGhT, a platform trial of patients with glioblastoma using Bayesian adaptive randomization.

Abstract Poster

Authors

null

Eudocia Quant Lee

Dana-Farber Cancer Institute, Boston, MA

Eudocia Quant Lee , Lorenzo Trippa , Geoffrey Fell , Rifaquat Rahman , Isabel Arrillaga-Romany , Jan Drappatz , Mary Roberta Welch , Evanthia Galanis , Manmeet Singh Ahluwalia , Howard Colman , Louis B. Nabors , Jaroslaw T. Hepel , David Schiff , Thomas Joseph Kaley , Christine Lu-Emerson , E. Antonio Chiocca , David A. Reardon , Keith L. Ligon , Brian Michael Alexander , Patrick Y. Wen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT02977780

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2012)

DOI

10.1200/JCO.2022.40.16_suppl.2012

Abstract #

2012

Poster Bd #

350

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Individualized screening trial of innovative glioblastoma therapy (INSIGhT).

Individualized screening trial of innovative glioblastoma therapy (INSIGhT).

First Author: Brian Michael Alexander

First Author: Eudocia Quant Lee

First Author: Howard Colman

First Author: Paul James Mulholland